Burning issues in acute heart failure management
| dc.contributor.author | Ker, James A. | |
| dc.contributor.author | Outhoff, Kim | |
| dc.date.accessioned | 2020-08-29T09:01:10Z | |
| dc.date.available | 2020-08-29T09:01:10Z | |
| dc.date.issued | 2019-12 | |
| dc.description.abstract | In general, heart failure is the end-stage manifestation of cardiovascular disease and is an important and increasing cause of morbidity worldwide. Acute heart failure, whether of new onset or an exacerbation of chronic heart failure, causes sudden congestion, typically presenting as pulmonary oedema. The mortality associated with acute heart failure is extremely high. Potentially life-saving treatments and other burning issues are highlighted in this review. | en_ZA |
| dc.description.department | Internal Medicine | en_ZA |
| dc.description.department | Pharmacology | en_ZA |
| dc.description.librarian | pm2020 | en_ZA |
| dc.description.uri | https://safpj.co.za/index.php/safpj | en_ZA |
| dc.identifier.citation | Ker, J.A. & Outhoff, K. 2019, 'Burning issues in blood pressure control', South African Family Practice, vol. 61, no. 6, art. a5063, pp. 6-8. | en_ZA |
| dc.identifier.issn | 2078-6190 (print) | |
| dc.identifier.issn | 1726-426X (online) | |
| dc.identifier.other | 10.4102/safp.v61i6.5063 | |
| dc.identifier.uri | http://hdl.handle.net/2263/75969 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | Medpharm Publications | en_ZA |
| dc.rights | © 2019 The Author(s).Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0]. | en_ZA |
| dc.subject | Pulmonary oedema | en_ZA |
| dc.subject | N-terminal pro-brain-type natriuretic peptide (NT-proBNP) | en_ZA |
| dc.subject | Loop diuretics | en_ZA |
| dc.subject | Ivabradine | en_ZA |
| dc.subject | Angiotensin receptor-neprilysin inhibitor (ARNI) | en_ZA |
| dc.subject | Acute heart failure | en_ZA |
| dc.title | Burning issues in acute heart failure management | en_ZA |
| dc.type | Article | en_ZA |